RAD51AP1 and ovarian cancer: In a study where two ovarian cancer cell lines were used (HEY and SKOV3), silencing of RAD51AP1 significantly inhibited the cell proliferation over 3 days [5] corroborating our initial findings in SKOV3 cells.